“Fiscal 2026 was a pivotal year for Hain. We simplified our portfolio, reduced debt, significantly improved free cash flow and exited the year with improving momentum across the business. Our fourth quarter results reflected encouraging sequential improvement, including organic net sales growth in
Lewis continued, “Assuming we successfully complete the transaction announced today to sell our International business and that we reach an agreement with our lenders to extend of our December debt maturity, we would expect to become a more focused North American company with leading brands in attractive categories and a streamlined operating model.”
FINANCIAL HIGHLIGHTS*
Summary of Fiscal Fourth Quarter Results Compared to the Prior Year Period
- Net sales were
$263 million , down 28% year-over-year, driven primarily by the divestiture of our North American snacks business.- Organic net sales decreased 2% compared to the prior year period.
- The decrease in organic net sales was comprised of a 2-point decrease in volume/mix and flat pricing.
- Organic net sales decreased 2% compared to the prior year period.
- Gross profit margin was 22.5%, a 200-basis point increase from the prior year period.
- Adjusted gross profit margin was 22.7%, a 230-basis point increase from the prior year period.
- Net loss was
$62 million , compared to a net loss of$273 million in the prior year period.- Adjusted net loss was
$4 million , compared to adjusted net loss of$2 million in the prior year period.
- Adjusted net loss was
- Adjusted EBITDA was
$19 million , compared to$20 million in the prior year period. - Loss per diluted share was
$0.68 , compared to a loss per diluted share of$3.06 in the prior year period.- Adjusted loss per diluted share was
$0.05 , compared to adjusted loss per diluted share of$0.02 in the prior year period.
- Adjusted loss per diluted share was
Summary of Fiscal Year 2026 Results Compared to the Prior Year
- Net sales were
$1,353 million , down 13% year-over-year.- Organic net sales decreased 3% compared to the prior year.
- The decrease in organic net sales was comprised of a 3-point decrease in volume/mix, partially offset by a 1-point increase in pricing.
- Organic net sales decreased 3% compared to the prior year.
- Gross profit margin was 20.1%, a 130-basis point decrease from the prior year.
- Adjusted gross profit margin was 20.5%, a 100-basis point decrease from the prior year.
- Net loss was
$305 million , compared to a net loss of$531 million in the prior year.- Adjusted net loss was
$16 million , compared to adjusted net income of$8 million in the prior year.
- Adjusted net loss was
- Adjusted EBITDA was
$89 million , compared to$114 million in the prior year. - Loss per diluted share was
$3.36 , compared to a loss per diluted share of$5.89 in the prior year.- Adjusted loss per diluted share was
$0.17 , compared to adjusted earnings per diluted share of$0.09 in the prior year.
- Adjusted loss per diluted share was
Cash Flow and Balance Sheet Highlights
- Net cash provided by operating activities was
$11 million in the fiscal fourth quarter, compared to net cash used in operating activities of$3 million in the prior year period; net cash provided by operating activities was$78 million in fiscal 2026 compared to$22 million in the prior year. - Free cash flow was
$7 million in the fiscal fourth quarter, compared to an outflow of$9 million in the prior year period; free cash flow was$58 million in fiscal 2026 compared to an outflow of$3 million in the prior year. - Total debt was
$558 million at the end of the fiscal fourth quarter, down from$705 million at the beginning of the fiscal year. - Net debt was
$500 million at the end of the fiscal fourth quarter, compared to$650 million at the beginning of the fiscal year. - The company ended the fiscal fourth quarter with a net secured leverage ratio of 4.5x as calculated under our credit agreement.
____________________
*This press release includes certain non-GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP financial measures. Reconciliations of non-GAAP financial measures to GAAP financial measures and other non-GAAP financial calculations are provided in the tables included in this press release.
SEGMENT HIGHLIGHTS
The company operates under two reportable segments:
| Q4 FY26 | Q4 FY26 YTD | |||||||||
| $ Millions | Reported Growth Y/Y | M&A/Exit Impact1 | FX Impact | Organic Growth Y/Y | $ Millions | Reported Growth Y/Y | M&A/Exit Impact1 | FX Impact | Organic Growth Y/Y | |
| 112 | -46% | -47% | -0% | 2% | 685 | -23% | -23% | 0% | 0% | |
| International | 151 | -4% | -1% | 1% | -4% | 668 | -0% | -0% | 4% | -4% |
| Total | 263 | -28% | -26% | 0% | -2% | 1,353 | -13% | -13% | 2% | -3% |
| * May not add due to rounding | ||||||||||
| 1 Reflects the impact within reported net sales growth of the following items that are excluded from organic net sales growth: net sales from divested brands (ParmCrisps®, Garden Veggie Snacks™, Terra® chips and Garden of Eatin’® snacks brands), held for sale businesses (Personal Care), discontinued brands, and exited product categories. | ||||||||||
Fiscal fourth quarter organic net sales increased by 2% year-over-year, primarily driven by growth in meal prep on strength in yogurt, partially offset by lower sales in baby & kids.
Segment gross profit was
Adjusted EBITDA in the fiscal fourth quarter was
Fiscal 2026 organic net sales were effectively flat year-over-year, as growth in meal prep and beverages was offset by lower sales in baby & kids.
Segment gross profit was
Adjusted EBITDA in fiscal 2026 was
International
Fiscal fourth quarter organic net sales decreased by 4% year-over-year, primarily driven by lower sales in meal prep and baby & kids, partially offset by growth in beverages.
Segment gross profit and adjusted gross profit in the fiscal fourth quarter were both
Adjusted EBITDA in the fiscal fourth quarter was
Fiscal 2026 organic net sales decreased by 4% year-over-year, primarily driven by lower sales in baby & kids and meal prep.
Segment gross profit and adjusted gross profit in fiscal 2026 were both
Adjusted EBITDA in fiscal 2026 was
CATEGORY HIGHLIGHTS
| Q4 FY26 | Q4 FY26 YTD | |||||||||
| $ Millions | Reported Growth Y/Y | M&A/Exit Impact1 | FX Impact | Organic Growth Y/Y | $ Millions | Reported Growth Y/Y | M&A/Exit Impact1 | FX Impact | Organic Growth Y/Y | |
| Baby & Kids | 52 | -12% | -1% | 0% | -11% | 215 | -11% | -1% | 2% | -12% |
| Beverages | 55 | -1% | 0% | 1% | -2% | 256 | 4% | -0% | 4% | 1% |
| 135 | -4% | -7% | 0% | 3% | 620 | -3% | -5% | 3% | 0% | |
| Snacks | 9 | -91% | -84% | 0% | -7% | 213 | -43% | -36% | 0% | -7% |
| Personal Care | 12 | -19% | n/a | n/a | n/a | 49 | -21% | n/a | n/a | n/a |
| Total | 263 | -28% | -26% | 0% | -2% | 1,353 | -13% | -13% | 2% | -3% |
| * May not add due to rounding | ||||||||||
| 1 Reflects the impact within reported net sales growth of the following items that are excluded from organic net sales growth: net sales from divested brands (ParmCrisps®, Garden Veggie Snacks™, Terra® chips and Garden of Eatin’® snacks brands), held for sale businesses (Personal Care), discontinued brands, and exited product categories. | ||||||||||
Baby & Kids
The fiscal fourth quarter organic net sales decline of 11% year-over-year was driven primarily by formula and purees in
The fiscal 2026 organic net sales decline of 12% year-over-year was driven primarily by purees in both regions and by formula in
Beverages
The fiscal fourth quarter organic net sales decline of 2% year-over-year was due to promotional activity in
Fiscal 2026 organic net sales increased by 1% year-over-year driven by tea in
Fiscal fourth quarter organic net sales increased by 3% year-over-year driven primarily by growth in yogurt in
Fiscal 2026 organic net sales were flat year-over-year as growth in yogurt in
Snacks
Following the disposition of the North American snacks business, the snacks category is comprised of jellies in the International segment. Organic net sales declined 7% year-over-year in both the fiscal fourth quarter and fiscal 2026.
Conference Call and Webcast Information
About The Hain Celestial Group, Inc.
Hain Celestial is a leading global health and wellness company whose purpose is to inspire healthier living for people, communities and the planet through better-for-you brands. For more than 30 years, Hain Celestial has intentionally focused on delivering nutrition and well-being that positively impacts today and tomorrow. Headquartered in Hoboken, N.J., Hain Celestial’s products across beverages, yogurt, baby/kids and meal preparation are marketed and sold around the world. Our leading brands include Celestial Seasonings® teas, The Greek Gods® yogurt, Earth’s Best® Organic and Ella’s Kitchen® baby and kids foods, Joya® and Natumi® plant-based beverages, Hartley’s® jelly, as well as Cully & Sully®, Yorkshire Provender®, New Covent Garden® soups, among others. For more information, visit www.hain.com and LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, our results may differ materially from those expressed or implied by such forward-looking statements. The words “believe,” “expect,” “anticipate,” “may,” “should,” “plan,” “intend,” “potential,” “will” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements include, among other things, our beliefs or expectations relating to our future performance, results of operations and financial condition; and our strategic initiatives and business strategy, including the pending sale of our International business.
Risks and uncertainties that may cause actual results to differ materially from forward-looking statements include: compliance with our credit agreement and our ability to refinance, retire and/or extend the maturity of our existing debt; our ability to execute our business strategy; our ability to complete the pending sale of our International business and manage the challenges and uncertainty facing our remaining business following the sale; challenges and uncertainty resulting from the impact of competition; changes to consumer preferences; our ability to manage our supply chain effectively; input cost inflation, including as a result of tariffs; reliance on independent contract manufacturers; disruption of operations at our manufacturing facilities; customer concentration; reliance on independent distributors; risks associated with operating internationally; risks associated with outsourcing arrangements; risks associated with geopolitical conflicts or events; our reliance on independent certification for a number of our products; our ability to attract and retain highly skilled people; risks related to tax matters; foreign currency exchange risk; general economic conditions; impairments in the carrying value of goodwill or other intangible assets; the reputation of our company and our brands; our ability to use and protect trademarks; cybersecurity incidents; disruptions to information technology systems; pending and future litigation, including litigation relating to Earth’s Best® baby food products; potential liability if our products cause illness or physical harm; the highly regulated environment in which we operate; compliance with data privacy laws; the adequacy of our insurance coverage; climate impacts; liabilities, claims or regulatory change with respect to environmental matters; the potential cessation of our common stock’s listing on The Nasdaq Stock Market LLC; and other risks and matters described in our most recent Annual Report on Form 10-K, our Annual Report on Form 10-K expected to be filed today and our other filings from time to time with the U.S. Securities and Exchange Commission.
We undertake no obligation to update forward-looking statements to reflect actual results or changes in assumptions or circumstances, except as required by applicable law.
Non-GAAP Financial Measures
This press release and the accompanying tables include non-GAAP financial measures, including, among others, organic net sales; adjusted gross profit and its related margin; adjusted operating income and its related margin; adjusted net (loss) income and its related margin; diluted net (loss) income per common share, as adjusted; adjusted EBITDA and its related margin; free cash flow; and net debt. The reconciliations of historic non-GAAP financial measures to the comparable GAAP financial measures are provided in the tables below. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read only in connection with the company’s consolidated financial statements presented in accordance with GAAP.
We define our non-GAAP financial measures as follows:
- Organic net sales: net sales excluding the impact of acquisitions, divestitures, held for sale businesses, discontinued brands, exited product categories and foreign exchange. To adjust organic net sales for the impact of acquisitions, the net sales of an acquired business are excluded from fiscal quarters constituting or falling within the current period and prior period where the applicable fiscal quarter in the prior period did not include the acquired business for the entire quarter. To adjust organic net sales for the impact of divestitures, held for sale businesses, discontinued brands and exited product categories, the net sales of a divested business, held for sale business, discontinued brand or exited product category are excluded from all periods. To adjust organic net sales for the impact of foreign exchange, current period net sales for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year.
- Adjusted gross profit and its related margin: gross profit, before plant closure related costs, net and warehouse and manufacturing consolidation and other costs, net.
- Adjusted operating income and its related margin: operating loss before goodwill impairment, costs associated with acquisitions, divestitures and other transactions, productivity and transformation costs, certain litigation expenses, net, long-lived asset and intangibles impairment, plant closure related costs, net, proceeds from insurance claim, CEO succession costs, warehouse and manufacturing consolidation and other costs, net.
- Adjusted net (loss) income and its related margin and diluted net (loss) income per common share, as adjusted: net loss, adjusted to exclude the impact of goodwill impairment, costs associated with acquisitions, divestitures and other transactions, productivity and transformation costs, certain litigation expenses, net, long-lived asset and intangibles impairment, plant closure related costs, net, proceeds from insurance claim, CEO succession costs, warehouse and manufacturing consolidation and other costs, net , unrealized currency losses, loss (gain) on sales of assets, and the related tax effects of such adjustments.
- Adjusted EBITDA and its related margin: net loss before depreciation and amortization, equity in net loss of equity-method investees, net interest expense, income taxes, stock-based compensation, net, unrealized currency losses, certain litigation expenses, net, proceeds from insurance claim, productivity and transformation costs, plant closure related costs, net, warehouse and manufacturing consolidation and other costs, net, CEO succession costs, costs associated with acquisitions, divestitures and other transactions, loss (gain) on sales of assets, goodwill impairment and long-lived asset and intangibles impairment.
- Free cash flow: net cash provided by (used in) operating activities less purchases of property, plant and equipment.
- Net debt: total debt less cash and cash equivalents.
We believe that the non-GAAP financial measures presented provide useful additional information to investors about current trends in the company’s operations and are useful for period-over-period comparisons of operations. We provide:
- Organic net sales to demonstrate the growth rate of net sales excluding the impact of acquisitions, divestitures, held for sale businesses, discontinued brands, and exited product categories and foreign exchange, and believe organic net sales is useful to investors because it enables them to better understand the growth of our business from period to period.
- Adjusted results as important supplemental measures of our performance and believe they are frequently used by securities analysts, investors and other interested parties in the evaluation of our Company and companies in our industry.
- Free cash flow as one factor in evaluating the amount of cash available for discretionary investments.
- Net debt as a useful measure to monitor leverage and evaluate the balance sheet.
We discuss the Company’s net secured leverage ratio as calculated under our credit agreement as a measure of our financial condition, liquidity and compliance with our credit agreement. For a description of the material terms of our credit agreement and risks of non-compliance with our credit agreement, see “Liquidity and Capital Resources” under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” in our most recent Annual Report on Form 10-K, our subsequent Quarterly Reports on Form 10-Q, our Annual Report on Form 10-K expected to be filed today and our other filings from time to time with the U.S. Securities and Exchange Commission.
Investor Relations Contact:
Alexis Tessier
Investor.Relations@hain.com
Media Contact:
Justin Godley
Justin.Godley@hain.com
| Consolidated Statements of Operations | |||||||||||||||
| (unaudited and in thousands, except per share amounts) | |||||||||||||||
| Fourth Quarter | Fourth Quarter Year to Date | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Net sales | $ | 263,069 | $ | 363,348 | $ | 1,353,429 | $ | 1,559,780 | |||||||
| Cost of sales | 203,866 | 289,002 | 1,081,317 | 1,225,722 | |||||||||||
| Gross profit | 59,203 | 74,346 | 272,112 | 334,058 | |||||||||||
| Selling, general and administrative expenses | 62,546 | 67,416 | 248,039 | 271,833 | |||||||||||
| 42,293 | 227,364 | 193,219 | 428,882 | ||||||||||||
| Amortization of acquired intangible assets | 5,077 | 1,300 | 10,802 | 6,476 | |||||||||||
| Productivity and transformation costs | 4,520 | 5,033 | 22,039 | 21,530 | |||||||||||
| Long-lived asset and intangibles impairment | 430 | 24,911 | 27,394 | 66,940 | |||||||||||
| Proceeds from insurance claim | - | - | (25,900 | ) | - | ||||||||||
| Operating loss | (55,663 | ) | (251,678 | ) | (203,481 | ) | (461,603 | ) | |||||||
| Interest and other financing expense, net | 11,882 | 12,841 | 56,957 | 51,253 | |||||||||||
| Other (income) expense, net | (1,523 | ) | (1,559 | ) | 46,342 | 875 | |||||||||
| Loss before income taxes and equity in net loss of equity-method investees | (66,022 | ) | (262,960 | ) | (306,780 | ) | (513,731 | ) | |||||||
| (Benefit) provision for income taxes | (4,097 | ) | 9,551 | (2,208 | ) | 15,297 | |||||||||
| Equity in net loss of equity-method investees | 24 | 104 | 351 | 1,813 | |||||||||||
| Net loss | $ | (61,949 | ) | $ | (272,615 | ) | $ | (304,923 | ) | $ | (530,841 | ) | |||
| Net loss per common share: | |||||||||||||||
| Basic | $ | (0.68 | ) | $ | (3.06 | ) | $ | (3.36 | ) | $ | (5.89 | ) | |||
| Diluted | $ | (0.68 | ) | $ | (3.06 | ) | $ | (3.36 | ) | $ | (5.89 | ) | |||
| Shares used in the calculation of net loss per common share: | |||||||||||||||
| Basic | 90,996 | 89,024 | 90,736 | 90,127 | |||||||||||
| Diluted | 90,996 | 89,024 | 90,736 | 90,127 | |||||||||||
| Consolidated Balance Sheets | |||||||
| (unaudited and in thousands) | |||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 58,078 | $ | 54,355 | |||
| Accounts receivable, net | 121,022 | 154,440 | |||||
| Inventories | 149,275 | 248,731 | |||||
| Prepaid expenses and other current assets | 82,017 | 43,169 | |||||
| Assets held for sale | 5,882 | 29,603 | |||||
| Total current assets | 416,274 | 530,298 | |||||
| Property, plant and equipment, net | 184,665 | 264,730 | |||||
| 246,079 | 500,961 | ||||||
| Trademarks and other intangible assets, net | 173,520 | 210,905 | |||||
| Operating lease right-of-use assets, net | 49,057 | 71,171 | |||||
| Other assets | 20,788 | 25,213 | |||||
| Total assets | $ | 1,090,383 | $ | 1,603,278 | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 125,497 | $ | 188,307 | |||
| Accrued expenses and other current liabilities | 143,560 | 68,426 | |||||
| Current portion of long-term debt | 557,552 | 7,653 | |||||
| Liabilities related to assets held for sale | 4,153 | 12,987 | |||||
| Total current liabilities | 830,762 | 277,373 | |||||
| Long-term debt, less current portion | 292 | 697,168 | |||||
| Deferred income taxes | 32,930 | 40,332 | |||||
| Operating lease liabilities, noncurrent portion | 44,409 | 65,284 | |||||
| Other noncurrent liabilities | 27,195 | 48,116 | |||||
| Total liabilities | 935,588 | 1,128,273 | |||||
| Stockholders’ equity: | |||||||
| Common stock | 1,135 | 1,125 | |||||
| Additional paid-in capital | 1,243,863 | 1,238,402 | |||||
| Retained (deficit) earnings | (258,245 | ) | 46,678 | ||||
| Accumulated other comprehensive loss | (101,463 | ) | (81,053 | ) | |||
| 885,290 | 1,205,152 | ||||||
| Less: | (730,495 | ) | (730,147 | ) | |||
| Total stockholders’ equity | 154,795 | 475,005 | |||||
| Total liabilities and stockholders’ equity | $ | 1,090,383 | $ | 1,603,278 | |||
| Consolidated Statements of Cash Flows | |||||||||||||||
| (unaudited and in thousands) | |||||||||||||||
| Fourth Quarter | Fourth Quarter Year to Date | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||||||||||
| Net loss | $ | (61,949 | ) | $ | (272,615 | ) | $ | (304,923 | ) | $ | (530,841 | ) | |||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||||||||||||
| Depreciation and amortization | 13,508 | 11,357 | 52,552 | 44,259 | |||||||||||
| Deferred income taxes | (5,759 | ) | (1,798 | ) | (8,446 | ) | (4,423 | ) | |||||||
| Equity in net loss of equity-method investees | 24 | 104 | 351 | 1,813 | |||||||||||
| Stock-based compensation, net | 1,279 | (1,273 | ) | 5,471 | 8,149 | ||||||||||
| 42,293 | 227,364 | 193,219 | 428,882 | ||||||||||||
| Long-lived asset and intangibles impairment | 430 | 24,911 | 27,394 | 66,940 | |||||||||||
| Loss (gain) on sale of assets | 209 | (5,396 | ) | 48,710 | (3,194 | ) | |||||||||
| Other non-cash items, net | 718 | 1,365 | 3,589 | 2,138 | |||||||||||
| Increase (decrease) in cash attributable to changes in operating assets and liabilities: | |||||||||||||||
| Accounts receivable | 18,165 | 26,565 | 35,806 | 25,204 | |||||||||||
| Inventories | 13,378 | 7,251 | 72,934 | (3,354 | ) | ||||||||||
| Other current assets | 2,148 | 11,393 | (37,621 | ) | 3,114 | ||||||||||
| Other assets and liabilities | (129 | ) | 1,881 | (4,138 | ) | 1,320 | |||||||||
| Accounts payable and accrued expenses | (12,872 | ) | (33,757 | ) | (6,629 | ) | (17,892 | ) | |||||||
| Net cash provided by (used in) operating activities | 11,443 | (2,648 | ) | 78,269 | 22,115 | ||||||||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||||||||||
| Purchases of property, plant and equipment | (4,609 | ) | (6,224 | ) | (20,613 | ) | (25,284 | ) | |||||||
| Proceeds from sale of assets, net | (204 | ) | 197 | 102,566 | 13,970 | ||||||||||
| Investments and joint ventures, including proceeds from dispositions | - | 10,000 | - | 12,570 | |||||||||||
| Proceeds from termination of net investment hedges | - | - | - | 2,363 | |||||||||||
| Net cash (used in) provided by investing activities | (4,813 | ) | 3,973 | 81,953 | 3,619 | ||||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||||||||||
| Borrowings under bank revolving credit facility | 34,000 | 65,000 | 190,000 | 221,000 | |||||||||||
| Repayments under bank revolving credit facility | (24,000 | ) | (59,500 | ) | (229,500 | ) | (245,500 | ) | |||||||
| Repayments under term loan | (1,875 | ) | (9,375 | ) | (108,600 | ) | (15,000 | ) | |||||||
| Payments of other debt, net | (24 | ) | (3,503 | ) | (2,666 | ) | (3,524 | ) | |||||||
| Employee shares withheld for taxes | (5 | ) | (33 | ) | (348 | ) | (1,414 | ) | |||||||
| Proceeds from termination of fair value hedge | - | - | - | 552 | |||||||||||
| Net cash provided by (used in) financing activities | 8,096 | (7,411 | ) | (151,114 | ) | (43,886 | ) | ||||||||
| Effect of exchange rate changes on cash | (959 | ) | 16,016 | (5,385 | ) | 18,200 | |||||||||
| Net increase in cash and cash equivalents | 13,767 | 9,930 | 3,723 | 48 | |||||||||||
| Cash and cash equivalents at beginning of period | 44,311 | 44,425 | 54,355 | 54,307 | |||||||||||
| Cash and cash equivalents at end of period | $ | 58,078 | $ | 54,355 | $ | 58,078 | $ | 54,355 | |||||||
| (unaudited and in thousands) | |||||||||||||||
| International | Corporate/Other | Hain Consolidated | |||||||||||||
| Net sales - Q4 FY26 | $ | 111,817 | $ | 151,252 | $ | - | $ | 263,069 | |||||||
| Net sales - Q4 FY25 | $ | 205,790 | $ | 157,558 | $ | - | $ | 363,348 | |||||||
| % change - FY26 net sales vs. FY25 net sales | (45.7 | )% | (4.0 | )% | (27.6 | )% | |||||||||
| Gross Profit | |||||||||||||||
| Q4 FY26 | |||||||||||||||
| Gross profit | $ | 34,161 | $ | 25,042 | $ | - | $ | 59,203 | |||||||
| Non-GAAP adjustments(1) | 580 | - | - | 580 | |||||||||||
| Adjusted gross profit | $ | 34,741 | $ | 25,042 | $ | - | $ | 59,783 | |||||||
| % change - FY26 gross profit vs. FY25 gross profit | (13.6 | )% | (28.1 | )% | (20.4 | )% | |||||||||
| % change - FY26 adjusted gross profit vs. FY25 adjusted gross profit | (12.1 | )% | (28.1 | )% | (19.6 | )% | |||||||||
| Gross margin | 30.6 | % | 16.6 | % | 22.5 | % | |||||||||
| Adjusted gross margin | 31.1 | % | 16.6 | % | 22.7 | % | |||||||||
| Q4 FY25 | |||||||||||||||
| Gross profit | $ | 39,522 | $ | 34,824 | $ | - | $ | 74,346 | |||||||
| Non-GAAP adjustments(1) | (15 | ) | - | - | (15 | ) | |||||||||
| Adjusted gross profit | $ | 39,507 | $ | 34,824 | $ | - | $ | 74,331 | |||||||
| Gross margin | 19.2 | % | 22.1 | % | 20.5 | % | |||||||||
| Adjusted gross margin | 19.2 | % | 22.1 | % | 20.5 | % | |||||||||
| Adjusted EBITDA | |||||||||||||||
| Q4 FY26 | |||||||||||||||
| Adjusted EBITDA | $ | 16,145 | $ | 12,324 | $ | (9,727 | ) | $ | 18,742 | ||||||
| % change - FY26 Adjusted EBITDA vs. FY25 Adjusted EBITDA | 55.3 | % | (41.1 | )% | 14.9 | % | (5.8 | )% | |||||||
| Adjusted EBITDA margin | 14.4 | % | 8.1 | % | 7.1 | % | |||||||||
| Q4 FY25 | |||||||||||||||
| Adjusted EBITDA | $ | 10,398 | $ | 20,938 | $ | (11,430 | ) | $ | 19,906 | ||||||
| Adjusted EBITDA margin | 5.1 | % | 13.3 | % | 5.5 | % | |||||||||
| (1)See accompanying table “Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net (Loss) Income and Adjusted Net (Loss) Income per Diluted Share” | |||||||||||||||
| (unaudited and in thousands) | |||||||||||||||
| International | Corporate/Other | Hain Consolidated | |||||||||||||
| Net sales - Q4 FY26 YTD | $ | 685,053 | $ | 668,376 | $ | - | $ | 1,353,429 | |||||||
| Net sales - Q4 FY25 YTD | $ | 888,626 | $ | 671,154 | $ | - | $ | 1,559,780 | |||||||
| % change - FY26 net sales vs. FY25 net sales | (22.9 | )% | (0.4 | )% | (13.2 | )% | |||||||||
| Gross Profit | |||||||||||||||
| Q4 FY26 YTD | |||||||||||||||
| Gross profit | $ | 156,895 | $ | 115,217 | $ | - | $ | 272,112 | |||||||
| Non-GAAP adjustments(1) | 5,382 | - | - | 5,382 | |||||||||||
| Adjusted gross profit | $ | 162,277 | $ | 115,217 | $ | - | $ | 277,494 | |||||||
| % change - FY26 gross profit vs. FY25 gross profit | (18.7 | )% | (18.4 | )% | (18.5 | )% | |||||||||
| % change - FY26 adjusted gross profit vs. FY25 adjusted gross profit | (16.6 | )% | (18.4 | )% | (17.4 | )% | |||||||||
| Gross margin | 22.9 | % | 17.2 | % | 20.1 | % | |||||||||
| Adjusted gross margin | 23.7 | % | 17.2 | % | 20.5 | % | |||||||||
| Q4 FY25 YTD | |||||||||||||||
| Gross profit | $ | 192,910 | $ | 141,148 | $ | - | $ | 334,058 | |||||||
| Non-GAAP adjustments(1) | 1,764 | - | - | 1,764 | |||||||||||
| Adjusted gross profit | $ | 194,674 | $ | 141,148 | $ | - | $ | 335,822 | |||||||
| Gross margin | 21.7 | % | 21.0 | % | 21.4 | % | |||||||||
| Adjusted gross margin | 21.9 | % | 21.0 | % | 21.5 | % | |||||||||
| Adjusted EBITDA | |||||||||||||||
| Q4 FY26 YTD | |||||||||||||||
| Adjusted EBITDA | $ | 61,236 | $ | 63,458 | $ | (35,686 | ) | $ | 89,008 | ||||||
| % change - FY26 Adjusted EBITDA vs. FY25 Adjusted EBITDA | (6.5 | )% | (26.2 | )% | 5.3 | % | (21.8 | )% | |||||||
| Adjusted EBITDA margin | 8.9 | % | 9.5 | % | 6.6 | % | |||||||||
| Q4 FY25 YTD | |||||||||||||||
| Adjusted EBITDA | $ | 65,470 | $ | 86,000 | $ | (37,681 | ) | $ | 113,789 | ||||||
| Adjusted EBITDA margin | 7.4 | % | 12.8 | % | 7.3 | % | |||||||||
| (1)See accompanying table “Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net (Loss) Income and Adjusted Net (Loss) Income per Diluted Share” | |||||||||||||||
| Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net (Loss) Income and Adjusted Net (Loss) Income per Diluted Share | |||||||||||||||
| (unaudited and in thousands, except per share amounts) | |||||||||||||||
| Reconciliation of Gross Profit, GAAP to Gross Profit, as Adjusted: | |||||||||||||||
| Fourth Quarter | Fourth Quarter Year to Date | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Gross profit, GAAP | $ | 59,203 | $ | 74,346 | $ | 272,112 | $ | 334,058 | |||||||
| Adjustments to Cost of sales: | |||||||||||||||
| Plant closure related costs, net | 580 | (15 | ) | 5,382 | 1,380 | ||||||||||
| Warehouse/manufacturing consolidation and other costs, net | - | - | - | 384 | |||||||||||
| Gross profit, as adjusted | $ | 59,783 | $ | 74,331 | $ | 277,494 | $ | 335,822 | |||||||
| Reconciliation of Operating Loss, GAAP to Operating Income, as Adjusted: | |||||||||||||||
| Fourth Quarter | Fourth Quarter Year to Date | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Operating loss, GAAP | $ | (55,663 | ) | $ | (251,678 | ) | $ | (203,481 | ) | $ | (461,603 | ) | |||
| Adjustments to Cost of sales: | |||||||||||||||
| Plant closure related costs, net | 580 | (15 | ) | 5,382 | 1,380 | ||||||||||
| Warehouse/manufacturing consolidation and other costs, net | - | - | - | 384 | |||||||||||
| Adjustments to Operating expenses(a): | |||||||||||||||
| 42,293 | 227,364 | 193,219 | 428,882 | ||||||||||||
| Transaction and integration costs, net | 9,390 | 86 | 14,125 | (488 | ) | ||||||||||
| Productivity and transformation costs | 4,520 | 5,033 | 22,039 | 21,530 | |||||||||||
| Certain litigation expenses, net(b) | 1,703 | 1,219 | 4,867 | 3,473 | |||||||||||
| Long-lived asset and intangibles impairment | 430 | 24,911 | 27,394 | 66,940 | |||||||||||
| Plant closure related costs, net | 93 | 1 | 374 | (165 | ) | ||||||||||
| Proceeds from insurance claim(c) | - | - | (25,900 | ) | - | ||||||||||
| CEO succession | - | 4,774 | - | 4,774 | |||||||||||
| Operating income, as adjusted | $ | 3,346 | $ | 11,695 | $ | 38,019 | $ | 65,107 | |||||||
| Reconciliation of Net Loss, GAAP to Net (Loss) Income, as Adjusted: | |||||||||||||||
| Fourth Quarter | Fourth Quarter Year to Date | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Net loss, GAAP | $ | (61,949 | ) | $ | (272,615 | ) | $ | (304,923 | ) | (530,841 | ) | ||||
| Adjustments to Cost of sales: | |||||||||||||||
| Plant closure related costs, net | 580 | (15 | ) | 5,382 | 1,380 | ||||||||||
| Warehouse/manufacturing consolidation and other costs, net | - | - | - | 384 | |||||||||||
| Adjustments to Operating expenses(a): | |||||||||||||||
| 42,293 | 227,364 | 193,219 | 428,882 | ||||||||||||
| Transaction and integration costs, net | 9,390 | 86 | 14,125 | (488 | ) | ||||||||||
| Productivity and transformation costs | 4,520 | 5,033 | 22,039 | 21,530 | |||||||||||
| Certain litigation expenses, net(b) | 1,703 | 1,219 | 4,867 | 3,473 | |||||||||||
| Long-lived asset and intangibles impairment | 430 | 24,911 | 27,394 | 66,940 | |||||||||||
| Plant closure related costs, net | 93 | 1 | 374 | (165 | ) | ||||||||||
| Proceeds from insurance claim(c) | - | - | (25,900 | ) | - | ||||||||||
| CEO succession | - | 4,774 | - | 4,774 | |||||||||||
| Adjustments to Interest and other expense (income), net(d): | |||||||||||||||
| Unrealized currency losses | 328 | 3,116 | 951 | 3,941 | |||||||||||
| Loss (gain) on sale of assets | 209 | (5,396 | ) | 48,710 | (3,194 | ) | |||||||||
| Adjustments to (Benefit) provision for income taxes: | |||||||||||||||
| Net tax impact of non-GAAP adjustments | (1,992 | ) | 9,838 | (1,859 | ) | 11,453 | |||||||||
| Net (loss) income, as adjusted | $ | (4,395 | ) | $ | (1,684 | ) | $ | (15,621 | ) | 8,069 | |||||
| Net loss margin | (23.5 | )% | (75.0 | )% | (22.5 | )% | (34.0 | )% | |||||||
| Adjusted net (loss) income margin | (1.7 | )% | (0.5 | )% | (1.2 | )% | 0.5 | % | |||||||
| Diluted shares used in the calculation of net loss per common share: | 90,996 | 89,024 | 90,736 | 90,127 | |||||||||||
| Diluted shares used in the calculation of adjusted net (loss) income per common share: | 90,996 | 89,024 | 90,736 | 90,380 | |||||||||||
| Diluted net loss per common share, GAAP | $ | (0.68 | ) | $ | (3.06 | ) | $ | (3.36 | ) | $ | (5.89 | ) | |||
| Diluted net (loss) income per common share, as adjusted | $ | (0.05 | ) | $ | (0.02 | ) | $ | (0.17 | ) | $ | 0.09 | ||||
| (a) Operating expenses include amortization of acquired intangibles, selling, general and administrative expenses, productivity and transformation costs, long-lived asset and intangibles impairment and goodwill impairment. | |||||||||||||||
| (b) Expenses and items relating to securities class action, baby food litigation and | |||||||||||||||
| (c) Represents a receivable under the Company’s representation and warranty insurance related to one of its prior acquisitions, which was collected on | |||||||||||||||
| (d) Interest and other expense (income), net includes interest and other financing expenses, net, unrealized currency losses, loss (gain) on sale of assets and other expense, net. | |||||||||||||||
| Organic Net Sales Growth by Segment | |||||||||||
| (unaudited and in thousands) | |||||||||||
| Q4 FY26 | International | Hain Consolidated | |||||||||
| Net sales | $ | 111,817 | $ | 151,252 | $ | 263,069 | |||||
| Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories | 14,056 | 731 | 14,787 | ||||||||
| Less: Impact of foreign currency exchange | (18 | ) | 1,596 | 1,578 | |||||||
| Organic net sales | $ | 97,779 | $ | 148,925 | $ | 246,704 | |||||
| Q4 FY25 | |||||||||||
| Net sales | $ | 205,790 | $ | 157,558 | $ | 363,348 | |||||
| Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories | 109,615 | 2,475 | 112,090 | ||||||||
| Organic net sales | $ | 96,175 | $ | 155,083 | $ | 251,258 | |||||
| Net sales decline | (45.7 | )% | (4.0 | )% | (27.6 | )% | |||||
| Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories | (47.4 | )% | (1.0 | )% | (26.2 | )% | |||||
| Less: Impact of foreign currency exchange | (0.0 | )% | 1.0 | % | 0.4 | % | |||||
| Organic net sales growth (decline) | 1.7 | % | (4.0 | )% | (1.8 | )% | |||||
| Q4 FY26 YTD | International | Hain Consolidated | |||||||||
| Net sales | $ | 685,053 | $ | 668,376 | $ | 1,353,429 | |||||
| Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories | 252,165 | 5,659 | 257,824 | ||||||||
| Less: Impact of foreign currency exchange | 249 | 29,363 | 29,612 | ||||||||
| Organic net sales | $ | 432,639 | $ | 633,354 | $ | 1,065,993 | |||||
| Q4 FY25 YTD | |||||||||||
| Net sales | $ | 888,626 | $ | 671,154 | $ | 1,559,780 | |||||
| Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories | 456,786 | 9,251 | 466,037 | ||||||||
| Organic net sales | $ | 431,840 | $ | 661,903 | $ | 1,093,743 | |||||
| Net sales decline | (22.9 | )% | (0.4 | )% | (13.2 | )% | |||||
| Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories | (23.1 | )% | (0.5 | )% | (12.6 | )% | |||||
| Less: Impact of foreign currency exchange | 0.0 | % | 4.4 | % | 1.9 | % | |||||
| Organic net sales growth (decline) | 0.2 | % | (4.3 | )% | (2.5 | )% | |||||
| Organic Net Sales Growth by Category | |||||||||||||||||||||||
| (unaudited and in thousands) | |||||||||||||||||||||||
| Q4 FY26 | Baby & Kids | Beverages | Snacks | Personal Care | Hain Consolidated | ||||||||||||||||||
| Net sales | $ | 52,313 | $ | 55,370 | $ | 135,004 | $ | 8,515 | $ | 11,867 | $ | 263,069 | |||||||||||
| Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories | 167 | - | 1,444 | 1,309 | 11,867 | 14,787 | |||||||||||||||||
| Less: Impact of foreign currency exchange | 203 | 778 | 569 | 28 | - | 1,578 | |||||||||||||||||
| Organic net sales | $ | 51,943 | $ | 54,592 | $ | 132,991 | $ | 7,178 | $ | - | $ | 246,704 | |||||||||||
| Q4 FY25 | |||||||||||||||||||||||
| Net sales | $ | 59,327 | $ | 55,783 | $ | 140,196 | $ | 93,324 | $ | 14,718 | $ | 363,348 | |||||||||||
| Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories | 879 | 42 | 10,852 | 85,599 | 14,718 | 112,090 | |||||||||||||||||
| Organic net sales | $ | 58,448 | $ | 55,741 | $ | 129,344 | $ | 7,725 | $ | - | $ | 251,258 | |||||||||||
| Net sales decline | (11.8 | )% | (0.7 | )% | (3.7 | )% | (90.9 | )% | (19.4 | )% | (27.6 | )% | |||||||||||
| Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories | (1.0 | )% | 0.0 | % | (6.9 | )% | (83.8 | )% | n/a | (26.2 | )% | ||||||||||||
| Less: Impact of foreign currency exchange | 0.3 | % | 1.4 | % | 0.4 | % | 0.0 | % | n/a | 0.4 | % | ||||||||||||
| Organic net sales (decline) growth | (11.1 | )% | (2.1 | )% | 2.8 | % | (7.1 | )% | n/a | (1.8 | )% | ||||||||||||
| Q4 FY26 YTD | Baby & Kids | Beverages | Snacks | Personal Care | Hain Consolidated | ||||||||||||||||||
| Net sales | $ | 214,828 | $ | 255,979 | $ | 620,121 | $ | 213,208 | $ | 49,293 | $ | 1,353,429 | |||||||||||
| Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories | 2,849 | 32 | 20,732 | 184,918 | 49,293 | 257,824 | |||||||||||||||||
| Less: Impact of foreign currency exchange | 3,667 | 8,897 | 16,013 | 1,035 | - | 29,612 | |||||||||||||||||
| Organic net sales | $ | 208,312 | $ | 247,050 | $ | 583,376 | $ | 27,255 | $ | - | $ | 1,065,993 | |||||||||||
| Q4 FY25 YTD | |||||||||||||||||||||||
| Net sales | $ | 241,552 | $ | 245,147 | $ | 639,507 | $ | 371,012 | $ | 62,562 | $ | 1,559,780 | |||||||||||
| Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories | 5,291 | 145 | 56,252 | 341,787 | 62,562 | 466,037 | |||||||||||||||||
| Organic net sales | $ | 236,261 | $ | 245,002 | $ | 583,255 | $ | 29,225 | $ | - | $ | 1,093,743 | |||||||||||
| Net sales (decline) growth | (11.1 | )% | 4.4 | % | (3.0 | )% | (42.5 | )% | (21.2 | )% | (13.2 | )% | |||||||||||
| Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories | (0.8 | )% | (0.0 | )% | (5.5 | )% | (36.1 | )% | n/a | (12.6 | )% | ||||||||||||
| Less: Impact of foreign currency exchange | 1.5 | % | 3.6 | % | 2.5 | % | 0.3 | % | n/a | 1.9 | % | ||||||||||||
| Organic net sales (decline) growth | (11.8 | )% | 0.8 | % | 0.0 | % | (6.7 | )% | n/a | (2.5 | )% | ||||||||||||
| Adjusted EBITDA | |||||||||||||||
| (unaudited and in thousands) | |||||||||||||||
| Fourth Quarter | Fourth Quarter Year to Date | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Net loss | $ | (61,949 | ) | $ | (272,615 | ) | $ | (304,923 | ) | $ | (530,841 | ) | |||
| Depreciation and amortization | 13,508 | 11,357 | 52,552 | 44,259 | |||||||||||
| Equity in net loss of equity-method investees | 24 | 104 | 351 | 1,813 | |||||||||||
| Interest expense, net | 10,431 | 11,689 | 50,154 | 47,773 | |||||||||||
| (Benefit) provision for income taxes | (4,097 | ) | 9,551 | (2,208 | ) | 15,297 | |||||||||
| Stock-based compensation, net | 1,279 | (1,273 | ) | 5,471 | 8,149 | ||||||||||
| Unrealized currency losses | 328 | 3,116 | 951 | 3,823 | |||||||||||
| Certain litigation expenses, net(a) | 1,703 | 1,219 | 4,867 | 3,473 | |||||||||||
| Proceeds from insurance claim(b) | - | - | (25,900 | ) | - | ||||||||||
| Restructuring activities | |||||||||||||||
| Productivity and transformation costs | 4,520 | 5,033 | 22,039 | 21,530 | |||||||||||
| Plant closure related costs, net | 673 | (14 | ) | 2,206 | 1,215 | ||||||||||
| Warehouse/manufacturing consolidation and other costs, net | - | - | - | 384 | |||||||||||
| CEO succession | - | 4,774 | - | 4,774 | |||||||||||
| Acquisitions, divestitures and other | |||||||||||||||
| Transaction and integration costs, net | 9,390 | 86 | 14,125 | (488 | ) | ||||||||||
| Loss (gain) on sale of assets | 209 | (5,396 | ) | 48,710 | (3,194 | ) | |||||||||
| Impairment charges | |||||||||||||||
| 42,293 | 227,364 | 193,219 | 428,882 | ||||||||||||
| Long-lived asset and intangibles impairment | 430 | 24,911 | 27,394 | 66,940 | |||||||||||
| Adjusted EBITDA | $ | 18,742 | $ | 19,906 | $ | 89,008 | $ | 113,789 | |||||||
| (a) Expenses and items relating to securities class action, baby food litigation and | |||||||||||||||
| (b) Represents a receivable under the Company’s representation and warranty insurance related to one of its prior acquisitions, which was collected on | |||||||||||||||
| Free Cash Flow | |||||||||||||||
| (unaudited and in thousands) | |||||||||||||||
| Fourth Quarter | Fourth Quarter Year to Date | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Net cash provided by (used in) operating activities | $ | 11,443 | $ | (2,648 | ) | $ | 78,269 | $ | 22,115 | ||||||
| Purchases of property, plant and equipment | (4,609 | ) | (6,224 | ) | (20,613 | ) | (25,284 | ) | |||||||
| Free cash flow | $ | 6,834 | $ | (8,872 | ) | $ | 57,656 | $ | (3,169 | ) | |||||
| Net Debt | |||||
| (unaudited and in thousands) | |||||
| Debt | |||||
| Current portion of long-term debt | $ | 557,552 | $ | 7,653 | |
| Long-term debt, less current portion | 292 | 697,168 | |||
| Total debt | 557,844 | 704,821 | |||
| Less: Cash and cash equivalents | 58,078 | 54,355 | |||
| Net debt | $ | 499,766 | $ | 650,466 | |
Source: 